The authors of a study in the April 2021 issue of The American Journal of Managed Care® discuss the possible reasons behind the link between care fragmentation and hospitalizations in veterans with diabetes, as well as potential opportunities to address disjointed care in the context of the widespread telehealth uptake seen during the COVID-19 pandemic.
In recent years, Congress has taken legislative action to allow veterans to more easily access care in the community that is paid for by the Department of Veterans Affairs, or VA. While this has helped dismantle some barriers to accessing care, it has also raised concerns about care fragmentation, or the extent to which a patient’s health care is spread across multiple providers. An ample body of literature has shown worse care outcomes and higher costs in the presence of care fragmentation, which is thought to arise when the different providers and organizations do not communicate effectively with one another.
On this episode of Managed Care Cast, we’re talking with two coauthors of an Original Research article published in our April 2021 issue. The article, “Ambulatory Care Fragmentation and Hospitalization Among Veterans With Diabetes,” examines the association between the system of one’s usual care provider and their level of care fragmentation with their odds of being hospitalized.
The authors joining us today are Lisa M. Kern MD, MPH, associate professor of medicine and of population health sciences at Weill Cornell Medicine, and Drew Helmer, MD, deputy director of the Center for Innovations in Quality, Effectiveness, and Safety at Michael E. DeBakey VA Medical Center in Houston, as well as senior faculty at Baylor College of Medicine.
Listen above or through one of these podcast services:
Sustaining Compassionate Trauma Care Across Communities
September 30th 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.
Listen
FTC Takes Legal Action Against 3 Largest PBMs Over Insulin Costs
September 20th 2024The Federal Trade Commission (FTC) has filed a legal complaint accusing the 3 largest pharmacy benefit managers (PBMs) in the US—Caremark, Express Scripts, and Optum Rx—of inflating insulin costs for patients, prompting renewed calls for PBM reform.
Read More
Antihyperglycemic Treatment Patterns for Chronic Kidney Disease and Type 2 Diabetes
September 5th 2024This study characterized antihyperglycemic medication use after chronic kidney disease onset among patients with type 2 diabetes to uncover potential unmet needs in clinical practice.
Read More